Answers are grounded in this paper and cite their sources.
Artemisia rutifolia Steph. ex Spreng is a vital plant species of the genus Artemisia with medicinal significance; however, a review of its ethnomedicinal implications, phytochemical composition and biological activities has been lacking. This review provides a comprehensive, species-specific synthesis on traditional utilization, phytochemical composition and biological activities of A. rutifolia . The published data on A. rutifolia from literature was searched by consulting Scopus, Google Scholar, PubMed and Web of Science databases using specific keywords. Ethnobotanical evidence indicated that the species is widely employed specifically in northern Pakistan to treat gastrointestinal disorders, parasitic infections, fever, hypertension, wounds, cough, dermatitis and microbial diseases. Reported data on phytochemistry revealed diverse oxygenated monoterpenes, sesquiterpenes, sesquiterpene lactones, phenolic acids, flavonoids and other specialized metabolites. Essential oils mainly contain 1,8-cineole, camphor and 4-phenylbutan-2-one, while solvent extracts possess diverse sesquiterpene lactone, phenolic and flavonoid constituents. The reviewed literature demonstrated that polar solvent extracts particularly methanol and ethanol, contain higher TPC and TFC with potential antioxidant and antimicrobial activities. Antimicrobial activities were generally more noticeable against Gram positive bacteria and were attributed to phenolics and flavonoids. Although, limited studies also reported cytotoxic activity against liver, gastric, colon, breast and cervical cancer cell lines, while anti-quorum sensing and enzyme inhibitory effects highlight its further therapeutic potentials. The available data supports A. rutifolia as a rich source of biologically active phytoconstituents with pharmaceutical potential. However, further bioactivity guided isolation, mechanistic investigations, in vivo studies, toxicological evaluation and clinical validation are required to facilitate the development of novel therapeutic agents.
No takes yet. Share an insight, caveat, or question.
Hussain et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: